afatinib tablets is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that: \u2022 has certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) gene(s). Your healthcare provider will perform a test to make sure that GILOTRIF is right for you. \u2022 has spread to other parts of the body (metastatic), and \u2022 has not been previously treated for metastatic lung cancer It is not known if GILOTRIF is safe and effective in treating people with lung cancer that has resistant abnormal EGFR genes. or is used to treat people with squamous cell lung cancer that: \u2022 has spread to other parts of the body, and \uf0b7 has been previously treated with chemotherapy that contains platinum. It is not known if GILOTRIF is safe and effective in children.<\/p>\n
Active ingredient: afatinib Inactive ingredients: Tablet Core: lactose monohydrate, microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate. Tablet Coating: hypromellose, polyethylene glycol, titanium dioxide, talc, polysorbate 80, FD&C Blue No. 2 (40 mg and 30 mg tablets only).<\/p>\n
If afatinib tablets are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
afatinib tablets is a kinase inhibitor indicated for: \u2022 First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test.<\/p>\n
Approval Date: 2013 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import afatinib tablets\u201d based on the information you provide.<\/p>\n
\nProprietary Name: On Request
\nActive Ingredient(s): afatinib tablets
\nDosage Forms And Strengths: Tablets: 40 mg, 30 mg, and 20 mg
\nCompany: Boehringer Ingelheim Pharmaceuticals, Inc.
\nCurrent indications: metastatic non-small cell lung cancer (NSCLC)
\nMedicine Approved By: \u2013<\/strong>\u00a0European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
\nSummary of FDA approved use on approval date:<\/strong>\u00a0Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n